Novocardia™ Announces Partnership with My Cardiologist

Novocardia, a value-based cardiovascular care delivery platform, announced Tuesday a partnership with My Cardiologist, a trusted provider of cardiovascular services in South Florida for more than 60 years. My Cardiologist employs 27 cardiologists and provides comprehensive cardiovascular care at six clinical office locations across Miami-Dade and Palm Beach counties. My Cardiologist’s clinicians hold expertise in general cardiology, electrophysiology, advanced heart failure, prevention and wellness, women’s heart health, and interventional cardiology – including the treatment of structural heart disease and peripheral artery disease. My Cardiologist offers a broad array of specialized diagnostic tests and treatments to evaluate, prevent, and treat cardiovascular disease.

Cardiovascular Associates of America Launches with Leading Partner Cardiovascular Medicine of Quad Cities

Today, Cardiovascular Associates of America (CVAUSA), a comprehensive physician management services organization recently formed by Webster Equity Partners, launched with Cardiovascular Medicine (CVM), a pre-eminent cardiovascular specialty practice located in the Quad Cities of Iowa & Illinois. Tim Attebery, DSc, MBA, FACHE is appointed Chief Executive Officer of CVAUSA. Most recently Attebery was CEO of the American College of Cardiology (ACC) and CEO of MedAxiom, an ACC company. “This is an exciting time for Cardiovascular Associates of America, and we are proud to be their first partner to form this premier national alliance,” said Edmund Coyne, M.D., F.A.C.C. president of Cardiovascular Medicine.

Assured Healthcare Partners (AHP) Announces Partnership with the Cardiovascular Health Clinic (CHC)

Assured Healthcare Partners (AHP), a leading healthcare services investor, today announced a partnership with the Cardiovascular Health Clinic (CHC) to form Cardiovascular Health Partners (CHP), a leading provider of heart and vascular care in the Central and Southern U.S. CHC is a physician-led organization that provides high quality clinical care across eleven locations throughout Oklahoma. In 2016, CHC developed one of the first ambulatory surgical centers focused on cardiovascular procedures in the U.S. and has rapidly grown to be a premier heart and vascular care provider in the Oklahoma market, with a group of highly experienced operators and staff.

DuneGlass Capital Announces New Physician-Owned Endovascular Practice Partnership, LifeFlow Partners

DuneGlass Capital, a growth-oriented investment firm focusing on partnering with entrepreneurs, is pleased to announce the formal launch of LifeFlow Partners, a physician-owned, private equity-backed endovascular practice partnership led by Dr. Hyung Kim as CEO. Created by a team of physicians, private equity, and management consulting professionals who have a combined 100 years of experience in healthcare, LifeFlow Partners provides a unique model for independent endovascular and interventional physicians to improve the operational and economic performance of their practices to further advance patient care and to maximize value.

5 Predictions on Cardiology in ASCs

Cardiologists and heart center administrators see a bright future for outpatient cardiology. But the optimal conditions for heart procedures to become more prevalent in ASCs are still evolving. Here are five predictions based on conversations Becker’s ASC Review has held with outpatient heart surgeons.

Cardiology Compensation Remains Stable despite Production Declines

MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its ninth annual Cardiovascular Provider Compensation and Production Survey Report revealing the true impact of the coronavirus pandemic on cardiovascular programs in 2020. While cardiology production was significantly down, cardiology compensation fared well in 2020. In fact, private group cardiologist compensation rose. Separately, a new patient panel measure shows a downward trend for median physician FTE per 1,000 active patients suggesting that the cardiology community is moving more care to APPs as part of its clinical strategy.

Novocardia™ Announces Partnership with First Coast Heart & Vascular Center

Novocardia, a value-based cardiovascular disease care delivery platform, today announced a partnership with First Coast Heart & Vascular Center, P.C., the largest independent cardiovascular disease physician group in Northeast Florida. Established in 2013, First Coast Heart & Vascular Center has grown rapidly to serve thousands of patients across Florida’s largest geographic market. First Coast Heart & Vascular Center employs sixteen cardiologists and eight advanced practice providers serving patients at nine practice locations across Duval, St. Johns, Flagler, Putnam and Clay counties.

Novocardia™ Announces $53.7M Financing Led by Deerfield Management

Novocardia, a value-based cardiovascular care delivery platform, announced Monday a $53.7 million Series A financing led by Deerfield Management Company. Novocardia is partnering with cardiologists to help them to grow their practices and navigate an increasingly complex healthcare landscape through participation in fee-for-value (FFV) reimbursement models. The company’s mission is to deliver better care at lower cost, through more proactive and prevention-focused care, leveraging technology, and creating aligned partnerships with health plans and referral partners.

Cardiology Procedures the Biggest Opportunity for ASC Growth, 4 Leaders Say

As CMS continues to remove cardiology surgeries from its inpatient-only list, ASC leaders expect these procedures to be critical to ASC growth. Four ASC leaders joined Becker’s Spine, Orthopedic & Pain Management-Driven ASC + The Future of Spine Conference hosted June 8-17. Here, they discuss the biggest opportunities for ASC growth post-pandemic.

US Deaths from Heart Disease and Diabetes Climbed amid COVID

The U.S. saw remarkable increases in the death rates for heart disease, diabetes and some other common killers in 2020, and experts believe a big reason may be that many people with dangerous symptoms made the lethal mistake of staying away from the hospital for fear of catching the coronavirus. The death rates — posted online this week by federal health authorities — add to the growing body of evidence that the number of lives lost directly or indirectly to the coronavirus in the U.S. is far greater than the officially reported COVID-19 death toll of nearly 600,000 in 2020-21.